carbamates and imatinib mesylate

carbamates has been researched along with imatinib mesylate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bekaert, S; Cools, J; De Keersmaecker, K; Folens, C; Lahortiga, I; Marynen, P; Mentens, N; Odero, MD; Van Neste, L; Vandenberghe, P1
Bright, SA; Brindisi, M; Butini, S; Campiani, G; Greene, LM; Greene, TF; Lawler, M; Meegan, MJ; Williams, DC; Zisterer, DM1
Chandrasekhar, M; Naga Raju, C; Prasad, GS; Rajendra, W; Seshaiah, K; Venkataramaiah, C1

Other Studies

3 other study(ies) available for carbamates and imatinib mesylate

ArticleYear
In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    Haematologica, 2008, Volume: 93, Issue:4

    Topics: Amyloid Precursor Protein Secretases; Antineoplastic Agents; Apoptosis; Benzamides; Benzodiazepinones; Carbamates; Cell Cycle; Cell Division; Cell Line, Tumor; Daunorubicin; Dexamethasone; Dipeptides; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia-Lymphoma, Adult T-Cell; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Notch1; Sequence Analysis, DNA; Vincristine

2008
The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
    Biochemical pharmacology, 2009, Feb-01, Volume: 77, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Carbamates; Cell Line, Tumor; Down-Regulation; Drug Synergism; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potentials; Oxazepines; Piperazines; Pyrimidines; Up-Regulation

2009
Synthesis, spectral characterization, docking studies and biological activity of urea, thiourea, sulfonamide and carbamate derivatives of imatinib intermediate.
    Molecular diversity, 2019, Volume: 23, Issue:3

    Topics: Anti-Infective Agents; Antioxidants; Aromatase; Carbamates; Chemistry Techniques, Synthetic; Imatinib Mesylate; Molecular Docking Simulation; Protein Conformation; Spectrum Analysis; Structure-Activity Relationship; Sulfonamides; Thiourea

2019